The Role of the XMD Dog in the Assessment of Myoblast Transfer Therapy

  • Barry J. Cooper
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 280)


The success of myoblast transfer therapy can be assessed in a variety of ways. However, from the point of view of the utilization of experimental models in the development of this form of therapy, the methods used to determine its success depend on the particular biological questions that are being addressed.


Muscular Dystrophy Satellite Cell Duchenne Dystrophy Single Muscle Cell Obligate Carrier 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    B.J. Cooper, N.J. Winand, H. Stedman, B.A. Valentine, E.P. Hoffman, L.M. Kunkel, M. Oronzi Scott, K.H. Fischbeck, J.N. Kornegay, R.J. Avery, J.R. Williams, R.D. Schmickel, and J.E. Sylvester, The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 334: 154–156 (1988).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1990

Authors and Affiliations

  • Barry J. Cooper
    • 1
  1. 1.Department of PathologyNY State College of Veterinary Medicine Cornell UniversityIthacaUSA

Personalised recommendations